Investigating malaria transmission and control in West-Central Africa
Official title: West-Central Africa EMERGENTS International Center of Excellence in Malaria Research (ICEMR)
Funded at University of Florida · NIH-11077824 · Data updated 2026-11-12
This study is looking at how malaria spreads in West-Central Africa, especially focusing on people who don’t show symptoms and the effects of insecticide resistance, to help improve ways to control the disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project start | April 22, 2024 |
| Project end | March 31, 2029 |
| Funding year | 2025 |
| Award (this year) | $747,123 |
| NIH project number | 5U19AI181594-02 |
| Project ID | NIH-11077824 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation include individuals living in malaria-endemic areas of West-Central Africa, particularly those who may be asymptomatic carriers of the disease.
✕Less likely to help
Patients living outside of malaria-endemic regions or those who do not have any exposure to malaria may not benefit from this research.
What this research studies
This research focuses on understanding the dynamics of malaria transmission in West-Central Africa, particularly the role of asymptomatic infections and the impact of insecticide resistance. The project aims to quantify the hidden reservoir of malaria in human populations and assess the spread of malaria vectors like Anopheles stephensi. By employing advanced epidemiological methods and field studies, the research seeks to provide insights that could enhance malaria control strategies in the region.
Why it matters
Potential benefit: If successful, this research could lead to improved malaria control measures, reducing the incidence and mortality associated with the disease.
How similar studies have gone: Previous research has shown success in understanding malaria transmission dynamics, but this specific focus on asymptomatic infections and the spread of new malaria vectors is relatively novel.
Where this research is happening
-
University of Florida
Gainesville, United States Active
Researchers
- Principal investigator: Dinglasan, Rhoel David Ramos — University of Florida
- Study coordinator: Dinglasan, Rhoel David Ramos
Related research
Other NIH-funded projects on the same topics.
-
Digital malaria surveillance in Ethiopia to improve outbreak detection
A collaboration to add a malaria-specific digital module to an existing surveillance system in Africa to help detect and respond to outbreaks faster.
-
Cross-sector partnership uses digital malaria surveillance in Ethiopia
A US-based team will adapt and test a digital malaria surveillance module in SORMAS to help detect and respond to malaria outbreaks in Ethiopia.
-
Malaria control project in Western Kenya to reduce illness and deaths
A large, multi-year effort in western Kenya will help track malaria spread and test ways to prevent transmission so fewer people get sick or die.
-
Optimizing tafenoquine dose to prevent relapse of vivax malaria in Asia
A study tests the best tafenoquine dose to prevent P. vivax malaria relapse in people in East Asia and Oceania.
-
Optimizing tafenoquine dose to prevent P. vivax malaria relapses in Asia
A study to find the best single-dose tafenoquine amount to prevent relapse of P. vivax malaria in people in East Asia and Oceania.
-
Severe malaria and brain risk in children
This grant studies how severe malaria in young children can affect brain development and long-term thinking and behavior, with a focus on kids in Uganda.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.